La maladie de Mondor : une complication de la chirurgie mammaire

Superficial thrombophlebitis (Mondor's Disease) after breast augmentation surgery

“…[1] The typical presentation is that of an abrupt onset of pain in the breast or chest wall, followed by the appearance of a firm, red, tender cord corresponding to the location of one of those three superficial chest wall veins. [1–2] Typically, the course of the disease is self-limiting, lasting weeks or rarely months, before resolving spontaneously without any risk of embolisation. [1–7]…”

“…However, in cases when the aetiology is not defined, patients should undergo a rigorous diagnostic investigation to determine the cause—a hidden breast cancer or lymphatic spread from carcinoma, a hypercoagulability state or a connective tissue disease. [2378]…”

“…[2–7] The results of the laboratory investigation (including hemogram, serum lipids, liver function tests, D-dimer, erythrocyte sedimentation rate, C-reactive protein, autoantibody screening, blood clotting levels, and thrombophylia screening) were normal. Breast and axillary ultrasound evidenced thrombophlebitis of the left thoracoepigastric vein and ruled out the possibility of breast cancer.…”

Superficial thrombophlebitis (Mondor′s Disease) after breast augmentation surgery

“…ondor's disease is characterized by superficial thrombophlebitis or phlebitis of the anterior or lateral wall of the chest involving the lateral thoracic, thoracoepigastric, or superior epigastric veins. [1][2][3][4] About 75% of the cases are women, generally between the second and fifth decades of life. Most cases are unilateral, and the most commonly affected vessel is the thoracoepigastric vein.…”

“…Most cases are unilateral, and the most commonly affected vessel is the thoracoepigastric vein. [1][2][3][4][5][6] The authors present here a case of superficial thrombophlebitis of the left anterolateral chest wall in a young female who had undergone breast augmentation five months prior to the appearance of the initial clinical symptoms. The authors also analysed the main etiologic components and preponderant clinical aspects of the disease, and determined all appropriate therapeutic measures.…”